<DOC>
	<DOCNO>NCT00021528</DOCNO>
	<brief_summary>STAR*D focus non-psychotic major depressive disorder adult see outpatient setting . The primary purpose research study determine treatment work best first treatment medication produce acceptable response . Participants first receive citalopram , SSRI medication ; symptom remain 8-12 week treatment , four level treatment offer , include cognitive therapy medication . There placebo treatment . Some patient may require combination two treatment obtain full benefit . Participation could last 15 27 month involve 30 clinic visit . Participants interview telephone throughout study symptom , daily functioning , treatment side effect , use health care system , satisfaction treatment . There one-year follow participant depression successfully treat</brief_summary>
	<brief_title>Sequenced Treatment Alternatives Relieve Depression ( STAR*D )</brief_title>
	<detailed_description>The STAR*D project enroll 4,000 outpatient ( age 18 -75 ) diagnose nonpsychotic Major Depressive Disorder . Participants initially treat ( open label ) citalopram , Level 1 treatment , minimum 8 week . Patients experience minimal benefit strongly encourage complete 12 week treatment order maximize chance symptom remission ( unless benefit see 8 week ) . All participant also receive brief depression educational program . At level change , participant ask indicate unacceptability potential treatment strategy ( e.g , augment switch medication ) . Participants eligible random assignment one acceptable medically safe treatment option . Level 2 : Participants either adequate response could tolerate citalopram eligible Level 2 . The Level 2 treatment strategy : ) Medication Psychotherapy Switch : switch sertraline , venlafaxineXR , bupropionSR , cognitive therapy ( CT ) . ii ) Medication Psychotherapy Augmentation : add citalopram either ) buspirone , b ) bupropionSR , c ) CT. iii ) Medication Only Switch Medication Only Augmentation option available participant CT unacceptable . iv ) Psychotherapy Only Switch Psychotherapy Only Augmentation option available participant additional medication unacceptable point study ( participant must willing continue citalopram ) Level 2A : Participants without satisfactory response Level 2 treatment eligible random assignment additional treatment Level 2A ( medically safe acceptable ) . Level 2A included participant enter Level 3 opportunity respond least 2 medication . Level 2A consist Medication Switch one two antidepressant medication ( venlafaxineXR bupropion SR ) . Level 3 : Participants without satisfactory response Level 2 , appropriate Level 2A , eligible random assignment one follow treatment ( acceptable medically safe ) : ) Medication Switch : ) mirtazapine b ) nortriptyline , tricyclic antidepressant . ii ) Medication Augmentation : Add ( current Level 2 Level 2A medication ) either : ) lithium b ) thyroid hormone ( T3 ) . Level 4 : Participants without adequate response Level 3 eligible random assignment Level 4 treatment ( acceptable medically safe ) . Level 4 include two Medication Switch option : tranylcypromine [ monoamine oxidase inhibitor ( MAOI ) ] , mirtazapine plus venlafaxineXR . After Level 4 , participant without adequate response discus acceptable treatment option physician . Once adequate response achieve Levels 2 , 2A , 3 4 , participant eligible enter 12-month follow-up , time remain current treatment ( ) ask symptom relevant information monthly telephone . ONLY PATIENTS BEING TREATED AT THE PARTICIPATING CLINICS ARE ELIGIBLE FOR THIS STUDY .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Mirtazapine</mesh_term>
	<mesh_term>Nortriptyline</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<mesh_term>Tranylcypromine</mesh_term>
	<mesh_term>Buspirone</mesh_term>
	<criteria>Outpatients age 18 75 year old nonpsychotic major depressive disorder ( HAMD score 14 great )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2006</verification_date>
	<keyword>Sequential Treatment</keyword>
	<keyword>Major Depression</keyword>
	<keyword>Treatment Resistant Depression</keyword>
</DOC>